Weekly Low-Dose Paclitaxel as Maintenance Treatment in Patients With Advanced Ovarian Cancer Who Had Microscopic Residual Disease at Second-Look Surgery After 6 Cycles of Paclitaxel/Platinum-Based Chemotherapy: Results of an Open Noncomparative Phase 2 Multicenter Italian Study (After-6 Protocol 2)
Angiolo Gadducci, Dionyssios Katsaros, Paolo Zola, Giovanni Scambia, Michela Ballardini, Enzo Pasquini, Carlo Fertonani, Lorenzo Maggi, Sergio Pecorelli, Pier Franco Conte, other members of the After-6 Italian Cooperative Group
International Journal of Gynecologic Cancer Apr 2009, 19 (4) 615-619; DOI: 10.1111/IGC.0b013e3181a4476b